Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Preferred Shares (2016)

UroGen Pharma (URGN) has disclosed Preferred Shares for 1 consecutive years, with $13000.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Preferred Shares changed N/A year-over-year to $13000.0, compared with a TTM value of $13000.0 through Dec 2016, changed N/A, and an annual FY2016 reading of $13000.0, changed N/A over the prior year.
  • Preferred Shares was $13000.0 for Q4 2016 at UroGen Pharma.
  • Across five years, Preferred Shares topped out at $13000.0 in Q4 2016 and bottomed at $13000.0 in Q4 2016.